ASCO GU 2020: A Next-Generation Aniten Compound Shows Promise Against Prostate Cancer
The agent demonstrated potential both as monotherapy and in combination therapy.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.